Search

Refine your search

Content type
Tags
Author
Jurisdiction
Language

7,345 results found

Eversheds Sutherland (International) LLP logo
Increasing globalization has changed the nature of business. It has also changed the type of advice our clients need. Eversheds Sutherland was formed…
Article

Eversheds Sutherland (International) LLP | European Union | 7 May 2021

EDPB guidelines on personal data breaches: what controllers need to know

The European Data Protection Board (EDPB) recently published the Guidelines on Examples Regarding Data Breach Notification. These guidelines will help…
GTDT PRO

Eversheds Sutherland (International) LLP | Hong Kong | 12 Mar 2021

Dominance in Hong Kong

Article

Eversheds Sutherland (International) LLP | European Union | 9 Dec 2020

European Union issues communication on COVID-19 vaccination strategy

According to the European Commission, the Swift development and global deployment of safe and effective vaccines against COVID-19 is key to resolving…
Article

Eversheds Sutherland (International) LLP | European Union | 25 Nov 2020

Short-term health preparedness for COVID-19 outbreaks

The European Union recently published a communication on the European Union's short-term health preparedness for COVID-19 outbreaks, which aims to…
Article

Eversheds Sutherland (International) LLP | European Union | 11 Nov 2020

Latest EU measures relating to COVID-19 pandemic - multicentre clinical trials

Since COVID-19 began to spread, the majority of the world's leading pharmaceutical laboratories have begun clinical trials to find both the right…
Article

Eversheds Sutherland (International) LLP | European Union | 14 Aug 2020

Cybersecurity in healthcare sector - Q&A on data breaches in relation to medical devices

The use of connected medical devices has changed the way in which the healthcare sector works. However, the various benefits based on the advance of…
Article

Eversheds Sutherland (International) LLP | European Union | 12 Aug 2020

Intellectual property in clinical trials

Clinical trial results may qualify for protection as IP rights and, as such, for commercialisation in the European Union. In order for clinical trial…
Article

Eversheds Sutherland (International) LLP | European Union | 20 May 2020

Conducting clinical trials during COVID-19 crisis: FAQs

COVID-19 is having a significant impact on clinical trials due to its affects on EU healthcare systems, including Limited or no patient contact…
Article

Eversheds Sutherland (International) LLP | European Union | 24 Apr 2020

How to protect against COVID-19 phishing attacks

According to the European Union Agency for Cybersecurity, there has been a strong increase in so-called 'phishing attacks'. Cyber criminals are…
Article

Eversheds Sutherland (International) LLP | European Union | 22 Apr 2020

EU postpones MDR due to COVID-19: losses and opportunities for medical device sector

In light of the COVID-19 pandemic's impact on medical device industry players (eg, manufacturers, notified bodies, suppliers, production sites and…
Previous page 1 2 3 ...